Lorcaserin Extended-Release Tablets and Sodium phenylbutyrate
Determining the interaction of Lorcaserin Extended-Release Tablets and Sodium phenylbutyrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: sodium phenylbutyrate
Brand name: Buphenyl
Synonyms: Sodium Phenylbutyrate Powder
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Sodium Phenylbutyrate Powder
- Lorcaserin Extended-Release Tablets-Sodium Phenylbutyrate Tablets
- Lorcaserin Extended-Release Tablets-Sodium phosphate dibasic and sodium phosphate monobasic
- Lorcaserin Extended-Release Tablets-Sodium phosphate dibasic and sodium phosphate monobasic Rectal
- Lorcaserin Extended-Release Tablets-Sodium phosphate p 32 Intravenous
- Lorcaserin Extended-Release Tablets-Sodium Phosphates
- Sodium phenylbutyrate-Lorcaserin Hydrochloride
- Sodium phenylbutyrate-Lorcaserin Tablets
- Sodium phenylbutyrate-Lorcet
- Sodium phenylbutyrate-Lorcet Plus
- Sodium phenylbutyrate-Lorcet Tablets
- Sodium phenylbutyrate-Lorlatinib